ProCE Banner Events

ASCO® Data Updates for Dual IO Combination Therapy for the Treatment of Unresectable or Metastatic Melanoma

Key updates from ASCO® in the advancements of DUAL IO therapies for metastatic melanoma and how the treatment options may improve outcomes for patients.

Key Takeaway:
- Treating patients with unresectable or Metastatic Melanoma with BRAF Status or Wild Type

This event has expired. No longer available for credits.

Time and location

Wednesday, July 24, 2024

12:15 PM - 1:00 PM Central Time (CT)

Virtual

Faculty
Daniel H. Johnson, MD

Deputy Director of Precision Therapies Program
Ochsner, MD Anderson Cancer Center

Sponsored By

ProCE Banner

466-US-2400108-05\24